New treatment helps alopecia patients regrow their hair

A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.

The study is based on Phase 3 clinical trials using baricitinib, a Janus kinase (JAK) inhibitor, to treat alopecia areata, an often disfiguring skin disease characterized by rapid loss of scalp hair, and sometimes eyebrows and eyelashes.

“This is so exciting, because …

Source image: Yalenews/ GoodNewsNetwork.org

Source text: GoodNewsNetwork.org